BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Laser capture microdissection
,
Rosiglitazone
,
rs2230926
,
PBX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Stathmin-4
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal brain
Thalamus lateral nuclei
Thalamus
Globus pallidus
Subthalamic nucleus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pain
Spinocerebellar ataxia
Nerve injury
Waardenburg's syndrome
Neuropathy
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Glial Cell Line-Derived Neurotrophic Factor
Buthionine Sulfoximine
2-aminoacetophenone
Pituitary Adenylate Cyclase-Activating Polypeptide
withaferin A
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR520G
AKAP13
TGIF1
SMARCC1
UPF3B
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
iPSC as a tool to characterize neuron gene expression profiles in Alzheimer's disease
Prostate cancer LNCaP cells with 3'-UTR or exon 7-specific ETV1 shRNA knockdown
Embryonic kidney HEK293 cells with Dox-induced expression of wildtype or mutant (Fn3NC) HCF2
Prostate cancer 22Rv1 cells treated with withaferin A
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Stathmin-4
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC
Biomarker Guided Treatment in Gynaecological Cancer
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium …
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent End…
Hepatocellular Carcinoma (HCC)_Torisel_
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ